Thymidine phosphorylase activity in human bladder cancer: Difference between superficial and invasive cancer

Clinical Cancer Research

Volumn 3, Issue 6, 1997, Pages 973-976

  Kubota, Yoshinobu ^a   Miura, Takeshi ^b   Moriyama, Masatoshi ^c   Noguchi, Sumio ^a   Matsuzaki, Junichi ^a   Takebayashi, Shigeo ^a   Hosaka, Masahiko ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b KANAGAWA CANCER CENTER   (Japan)

^c Yokohama Municipal Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOXIFLURIDINE; FLUOROURACIL; THYMIDINE PHOSPHORYLASE;

ANGIOGENESIS; ARTICLE; BLADDER CANCER; CANCER INVASION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SUPERFICIAL CANCER;

EPITHELIAL CELLS; FLOXURIDINE; FLUOROURACIL; HUMANS; KINETICS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; THYMIDINE PHOSPHORYLASE; URINARY BLADDER; URINARY BLADDER NEOPLASMS;

EID: 0030996895     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Weber, G. Biochemical strategy of cancer cells and the design of chemotherapy. Cancer Res., 43: 3466-3492, 1983.
2. Zimmerman, M., and Seidenberg, J. Thymidine phosphorylase and nucleoside deoxyribosyltransferase in normal and malignant tissues. J. Biol. Chem., 239: 2618-2621, 1964.
3. Yoshimura, A., Kuwazuru, Y., Furukawa, T., Yoshida, H., Yamada, K., and Akiyama, S. Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes, and tumors. Biochem. Biophys. Acta, 1034: 107-113, 1990.
4. Eda, H., Fujimoto, K., Watanabe, S., Ura, M., Hino, A., Tanaka, Y., Wada, K., and Ishitsuka, H. Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine. Cancer Chemother. Pharmacol., 32: 333-338, 1993.
5. Ishitsuka, H., Miwa, M., Takemoto, K., Fukuoka, K., Itoga, A., and Maruyama, H. B. Role of uridine phosphorylase for antitumor activity of 5′-deoxy-5-fluorouridine. Jpn. J. Cancer Res., 71: 112-123, 1980.
6. Kono, A., Hara, Y., Sugata, S., Karube, Y., Matsushima, Y., and Ishitsuka, H. Activation of 5′-deoxy-5-fluorouridine by thymidine phosphorylase in human tumors. Chem. & Pharm. Bull. (Tokyo), 31: 175-178, 1983.
7. Miwa, M., Cook, A., and Ishitsuka, H. Enzymatic cleavage of various fluorinated pyrimidine nucleosides to 5-fluorouracil and their antiproliferative activities in human and murine tumor cells. Chem. & Pharm. Bull. (Tokyo), 34: 4225-4232, 1986.
8. Furukawa, T., Yoshimura, A., Sumizawa, T., Haraguchi, M., and Akiyama, S. Angiogenic factor. Nature (Lond.), 356: 668, 1992.
9. Moghaddam, A., and Bicknell, R. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry, 31: 12141-12146, 1992.
10. O'Brien, T., Cranston, D., Fuggle, S., Bicknell, K., and Harris, A. L. Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res., 55: 510-513, 1995.
11. Lowry, O. H., Rosebroough, N. J., Fair, A. C., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265-275, 1951.
12. Haraguchi, M., Miyadera, K., Uemura, K., Sumizawa, I., Furukawa, T., Yamada, K., and Akiyama, S., and Yamada, Y. Angiogenic activity of enzymes. Nature (Lond.), 368: 198, 1994.
13. Aburuzzo, L. V., Thornton, A. J., Liebert, M., Grossman, H. B., Evanoff, H., Westwick, J., Stricter, R. M., and Kunkel, S. L. Cytokine-induced gene expression of interleukin 8 in human transitional cell carcinomas and renal cell carcinomas. Am. J. Pathol., 140: 365-373, 1992.